Sanofi: Stomach Neoplasms trials
The registry lists 15 Stomach Neoplasms studies with Sanofi as lead sponsor. 1 are open to participants now and 4 have results posted.
Phase 1 4Phase 2 10Phase 3 4(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- A Dose Optimization/Expansion Study of SAR445877 in Adult Chinese Participants With Advanced Gastric or Gastroesophageal Junction CancerRecruitingNCT07692204Phase 2
- A Study of SAR444245 Combined With Other Anticancer Therapies for the Treatment of Participants With Gastrointestinal Cancer (Master Protocol) (Pegathor Gastrointestinal 203)CompletedNCT05104567Phase 2Results posted
- A Phase 1/2, Open-label, Multi-center Study of the Safety and Efficacy of Alomfilimab (KY1044) as Single Agent and in Combination With Anti-PD-L1 (Atezolizumab) in Adult Patients With Selected Advanced MalignanciesTerminatedNCT03829501Phase 1/2Results posted
- Docetaxel+Oxaliplatin+S-1 (DOS) Regimen as Neoadjuvant Chemotherapy in Advanced Gastric CancerCompletedNCT01515748Phase 3Results posted
- Docetaxel and Oxaliplatin in Gastric CancerCompletedNCT00382720Phase 2Results posted
- (VELA) Study of BLU-222 in Advanced Solid TumorsTerminatedNCT05252416Phase 1
- Dose Escalation and Expansion Study of SAR443216 in Participants With Relapsed/Refractory HER2 Expressing Solid TumorsTerminatedNCT05013554Phase 1
- Cabazitaxel in Asian Patients With Advanced Gastric Cancer Who Failed Prior ChemotherapyCompletedNCT01497964Phase 1/2
- Docetaxel + Oxaliplatin + S-1 in Potentially Operable Gastric or Gastroesophageal AdenocarcinomaCompletedNCT00816543Phase 2
- Taxotere New Indication - Gastric Cancer Treatment Registration TrialCompletedNCT00811447Phase 3
- A Phase II Study of Oxaliplatin in Association With 5FU and Folinic Acid in the Treatment of Subjects With Non-Surgical or Advanced Metastatic Gastric CancerCompletedNCT00611507Phase 2
- Capecitabine and Oxaliplatin Adjuvant Study in Stomach CancerCompletedNCT00411229Phase 3
- Docetaxel in Locally Advanced Gastric AdenocarcinomaCompletedNCT00343239Phase 2
- Randomized Multicenter Study Comparing Docetaxel Plus Cisplatin and 5-FU to Cisplatin Plus 5-FU in Advanced Gastric CancerCompletedNCT00290966Phase 2/3
- Oxaliplatin in Gastric CancerCompletedNCT00263354Phase 2